Based on the positive Phase 1 results and approval from Canadian regulatory authorities, Medicago has decided to commence the Phase 2/3 clinical trial with ... Nov 13
Through this merger, the company will be able to deliver novel, multi-indication platform drugs designed to extend healthy lifespan and treat the source of ... Nov 13
This initiative supports pharmaceutical companies by providing them for free with the necessary tools to protect COVID-19 relevant medicines and vaccines against counterfeiting... Nov 13
-Advertisements-